Original(603991)
Search documents
至正股份跌7.03%,上榜营业部合计净卖出2141.98万元
Zheng Quan Shi Bao· 2025-08-12 11:28
7月15日公司发布上半年业绩预告,预计实现净利润-2800.00万元至-2000.00万元,同比变动区间 为-352.61%~-223.30%。 至正股份8月12日交易公开信息 证券时报·数据宝统计显示,上榜的前五大买卖营业部合计成交1.10亿元,其中,买入成交额为4412.60 万元,卖出成交额为6554.58万元,合计净卖出2141.98万元。 具体来看,今日上榜营业部中,第一大买入营业部为中泰证券股份有限公司宁波江东北路证券营业部, 买入金额为1278.95万元,第一大卖出营业部为华泰证券股份有限公司深圳深南大道证券营业部,卖出 金额为1873.00万元。 资金流向方面,今日该股主力资金净流出8998.89万元,其中,特大单净流出2678.24万元,大单资金净 流出6320.64万元。近5日主力资金净流出1.92亿元。 4月29日公司发布的一季报数据显示,一季度公司共实现营业收入5119.06万元,同比增长38.67%,实现 净利润-1423.15万元。 至正股份(603991)今日下跌7.03%,全天换手率10.22%,成交额4.92亿元,振幅12.59%。龙虎榜数据显 示,营业部席位合计净卖出214 ...
至正股份跌7.03%,上榜营业部合计净卖出2141.98万元
Zheng Quan Shi Bao Wang· 2025-08-12 10:00
Group 1 - The stock of Zhizheng Co., Ltd. (603991) experienced a decline of 7.03% today, with a turnover rate of 10.22% and a trading volume of 492 million yuan, showing a fluctuation of 12.59% [2] - The stock was listed on the Shanghai Stock Exchange due to a daily price deviation of -7.54%, with a net selling amount of 21.42 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction of 110 million yuan, with a buying amount of 44.13 million yuan and a selling amount of 65.55 million yuan, resulting in a net selling of 21.42 million yuan [2] Group 2 - The largest buying brokerage was Zhongtai Securities Co., Ltd. with a purchase amount of 12.79 million yuan, while the largest selling brokerage was Huatai Securities Co., Ltd. with a selling amount of 18.73 million yuan [2][3] - The stock saw a net outflow of 89.99 million yuan in main funds today, including a net outflow of 26.78 million yuan from large orders and 63.21 million yuan from major funds [2] - Over the past five days, the net outflow of main funds reached 192 million yuan [2] Group 3 - On April 29, the company reported its Q1 results, achieving an operating income of 51.19 million yuan, a year-on-year increase of 38.67%, but a net loss of 14.23 million yuan [2] - On July 15, the company released a half-year performance forecast, expecting a net loss between 28 million yuan and 20 million yuan, with a year-on-year change range of -352.61% to -223.30% [3]
至正股份重大资产置换事项通过交易所审核
Zheng Quan Ri Bao Wang· 2025-08-12 07:46
Group 1 - The core point of the article is that Shenzhen Zhizheng High Polymer Materials Co., Ltd. has received approval from the Shanghai Stock Exchange's M&A Review Committee for a significant asset swap, issuance of shares, and cash payment to acquire the equity and control of Advanced Assembly Materials International Limited, while divesting 100% equity of Shanghai Zhizheng New Materials Co., Ltd. [1] - The transaction aims to enhance the company's position in advanced packaging materials by acquiring a foreign entity, which indicates a strategic move towards international expansion and diversification of its product offerings [1] - The M&A Review Committee's meeting on August 11, 2025, concluded that the transaction meets the restructuring conditions and information disclosure requirements, which is a positive indicator for the company's future operations [1]
至正股份30亿元重大资产重组获通过 华泰联合建功
Zhong Guo Jing Ji Wang· 2025-08-12 06:12
中国经济网北京8月12日讯上交所网站昨日晚间披露上海证券交易所并购重组审核委员会2025年第10次 审议会议结果公告。深圳至正高分子材料股份有限公司(简称"至正股份(603991)",603991.SH)发行 股份购买资产符合重组条件和信息披露要求。 重组委会议现场问询的主要问题: 1.请上市公司代表说明:AAMI市场法评估选取可比公司考量因素的合理性,是否符合准则相关规定以 及行业惯例,估值是否公允。请独立财务顾问代表和评估师代表发表明确意见。 2.请上市公司代表结合行业发展、可比公司情况、至正新材料历史估值、近年生产经营情况、未来发展 趋势、评估方法选取的主要考虑等,说明置出资产估值合理性。请独立财务顾问代表和评估师代表发表 明确意见。 3.请上市公司代表:(1)结合应收款项、存货和销售商品、提供劳务收到的现金等项目的变动情况,说明 AAMI2024年收入确认是否准确。(2)结合寄售业务合同约定,存货管理方式和责任,存货结转、盘点及 余额变动等情况,说明寄售模式下相关内部控制是否健全有效。请独立财务顾问代表和会计师代表发表 明确意见。 需进一步落实事项: 上市公司拟通过重大资产置换、发行股份及支付现金的方 ...
至正股份(603991.SH)重大资产重组相关事项获上交所重组委审议通过
智通财经网· 2025-08-11 22:40
登录新浪财经APP 搜索【信披】查看更多考评等级 至正股份(603991.SH)公告,公司拟通过重大资产置换、发行股份及支付现金的方式取得先进封装材料 国际有限公司的股权及其控制权、置出上海至正新材料有限公司100%股权并募集配套资金。上交所重 组委已于2025年8月11日召开2025年第10次并购重组审核委员会审议会议,对公司本次交易的申请进行 了审议。根据上交所重组委发布的《上海证券交易所并购重组审核委员会2025年第10次审议会议结果公 告》,本次会议的审议结果为:本次交易符合重组条件和信息披露要求。 ...
至正股份重大资产重组相关事项获上交所重组委审议通过
Zhi Tong Cai Jing· 2025-08-11 22:39
至正股份(603991)(603991.SH)公告,公司拟通过重大资产置换、发行股份及支付现金的方式取得先 进封装材料国际有限公司的股权及其控制权、置出上海至正新材料有限公司100%股权并募集配套资 金。上交所重组委已于2025年8月11日召开2025年第10次并购重组审核委员会审议会议,对公司本次交 易的申请进行了审议。根据上交所重组委发布的《上海证券交易所并购重组审核委员会2025年第10次审 议会议结果公告》,本次会议的审议结果为:本次交易符合重组条件和信息披露要求。 ...
至正股份: 至正股份关于重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易事项获得上海证券交易所并购重组审核委员会审核通过的公告
Zheng Quan Zhi Xing· 2025-08-11 16:25
Group 1 - The company plans to conduct a major asset swap, issue shares, and pay cash to acquire the equity and control of Advanced Assembly Materials International Limited, while divesting 100% of Shanghai Zhizheng New Materials Co., Ltd. [1] - The Shanghai Stock Exchange's M&A Review Committee approved the company's transaction application, confirming it meets restructuring conditions and information disclosure requirements [2] - The transaction is subject to approval from the China Securities Regulatory Commission for registration, with uncertainties regarding the completion and timing of the registration process [2]
至正股份(603991) - 至正股份关于重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易事项获得上海证券交易所并购重组审核委员会审核通过的公告
2025-08-11 13:30
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 深圳至正高分子材料股份有限公司(以下简称"公司")拟通过重大资产置 换、发行股份及支付现金的方式取得先进封装材料国际有限公司(Advanced Assembly Materials International Limited)的股权及其控制权、置出上海至正新材 料有限公司 100%股权并募集配套资金(以下简称"本次交易")。 深圳至正高分子材料股份有限公司 关于重大资产置换、发行股份及支付现金购买资产并 募集配套资金暨关联交易事项获得上海证券交易所 并购重组审核委员会审核通过的公告 证券代码:603991 证券简称:至正股份 公告编号:2025-048 上海证券交易所并购重组审核委员会(以下简称"上交所重组委")于 2025 年 8 月 11 日召开 2025 年第 10 次并购重组审核委员会审议会议,对公司本次交 易的申请进行了审议。根据上交所重组委发布的《上海证券交易所并购重组审核 委员会 2025 年第 10 次审议会议结果公告》,本次会议的审议结果为:本次交易 符合重组条 ...
短线防风险 17只个股短期均线现死叉
Zheng Quan Shi Bao Wang· 2025-08-11 03:54
Market Overview - The Shanghai Composite Index closed at 3653.50 points, with a change of +0.51% [1] - The total trading volume of A-shares reached 1,149.623 billion yuan [1] Technical Analysis - A total of 17 A-shares experienced a "death cross" where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Angli (002940) with a distance of -1.91% - Chengdu Xian Dao (688222) with a distance of -1.51% - Saiseng Pharmaceutical (300485) with a distance of -1.38% [1] Individual Stock Performance - Angli (002940) saw a daily increase of 2.02% with a turnover rate of 4.48% [1] - Chengdu Xian Dao (688222) increased by 1.47% with a turnover rate of 2.10% [1] - Saiseng Pharmaceutical (300485) experienced a slight decrease of -0.14% with a turnover rate of 3.10% [1] - Other stocks with notable performance include: - Jintai (688443) up by 1.78% - Changshan Pharmaceutical (300255) up by 2.29% - Zhizheng (603991) down by -1.69% [1]
短线防风险 20只个股短期均线现死叉
Zheng Quan Shi Bao Wang· 2025-08-11 03:12
Market Overview - The Shanghai Composite Index is at 3639.18 points with a change of 0.11% [1] - The total trading volume of A-shares is 832.786 billion yuan [1] Stocks with Death Cross - 20 A-shares have seen their 5-day moving average cross below the 10-day moving average [1] - Notable stocks include: - Angli (002940) with a 5-day moving average of 56.59 yuan, down 1.78% from the 10-day moving average [1] - Chengdu Xian Dao (688222) with a 5-day moving average of 23.11 yuan, down 1.64% [1] - Sai Sheng Pharmaceutical (300485) with a 5-day moving average of 14.83 yuan, down 1.40% [1] Additional Stock Data - Other stocks with significant moving average changes include: - Zhi Xiang (688443) with a 5-day moving average of 33.34 yuan, down 0.85% [1] - Changshan Pharmaceutical (300255) with a 5-day moving average of 41.59 yuan, down 0.68% [1] - Zhi Zheng (603991) with a 5-day moving average of 72.69 yuan, down 0.40% [1] Performance Summary - The performance of various stocks shows a mix of slight gains and losses, with some stocks like Angli and Chengdu Xian Dao experiencing notable declines in their moving averages [1][2] - The overall market sentiment appears cautious, reflected in the trading volumes and the number of stocks showing bearish signals [1]